Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000414

Type of data
NGS (scRNA-seq, Exome, RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
317 GB
File formats
  • FASTQ
Research
hum0277
Date published
2022-08-25
Date modified
2022-11-29
DDBJ Search
JGAD000414 (opens in a new tab)
JGA Study
JGAS000303 (opens in a new tab)

Analysis method

RNA-seq

Materials and participants
BHD (ICD10: Q878) -associated RCC (ICD10: C64): 10 cases
(tumor: 16 samples, normal kidney: 5 samples)
chRCC (ICD10: C64): 21 cases
(tumor: 21 samples)
sporadic oncocytoma (ICD10: C64): 7 cases
(tumor: 7 samples)
RCC (ICD10: C64): 167 cases
(tumor: 167 samples)
  • Health status
    Affected
  • Subject count
    205 (Individual)
Disease
BHD (Q878)
associated RCC (C64)
chRCC (C64)
sporadic oncocytoma (C64)
RCC (C64)
Sample description
RNAs extracted from tumor and non-tumor tissues
  • Tissue
    Kidney
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
TruSeq RNA CD Index Kit (Dual Index)
TruSeq Stranded mRNA Library Prep Kit
Fragmentation
Heat treatment
Platform
Illumina HiSeq 2500
Read type
Paired-end
Read length
126 bp (read1)
126 bp (read2)
Data use policy
NBDC data sharing policy (JGAP000001)

scRNA-seq

Materials and participants
RCC (ICD10: C64): 7 cases
BHD (ICD10: Q878) -associated RCC: 2 cases (2 samples)
HLRCC (MedGen ID: 353771) -associated RCC: 1 case (2 samples)
VHL (ICD10: Q858) -associated RCC: 2 cases (2 samples)
ccRCC: 2 cases (4 tumor samples and 2 normal kidney tissues)
  • Health status
    Affected
  • Subject count
    7 (Individual)
Disease
RCC (C64)
BHD (Q878)
VHL (Q858)
Sample description
RNAs extracted from single cells of tumor and non-tumor tissues
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
scRNA-seq
Target
N/A
Reagent kit
Chromium Single Cell 3'
Fragmentation
N/A
Platform
Illumina NextSeq 500
Illumina NovaSeq 6000
Read type
Paired-end
Read length
8 bp (index)
28 bp (read1)
91 bp (read2)
Data use policy
NBDC data sharing policy (JGAP000001)

WES

Materials and participants
RCC (ICD10: C64): 7 cases
BHD (ICD10: Q878) -associated RCC: 2 cases
(tumor: 2 samples, normal kidney: 2 samples)
HLRCC (MedGen ID: 353771) -associated RCC: 1 case
(tumor: 2 samples, normal kidney: 1 sample)
VHL (ICD10: Q858) -associated RCC: 2 cases
(tumor: 2 samples, normal kidney: 2 samples)
ccRCC: 2 cases
(tumor: 4 samples, normal kidney: 2 samples)
  • Health status
    Affected
  • Subject count
    7 (Individual)
Disease
RCC (C64)
BHD (Q878)
VHL (Q858)
Sample description
DNAs extracted from tumor and non-tumor tissues
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
SureSelect Human All Exon V6
Fragmentation
Ultrasonic fragmentation
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp (read1)
150 bp (read2)
Data use policy
NBDC data sharing policy (JGAP000001)